HK1075452A1 - Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments - Google Patents

Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments

Info

Publication number
HK1075452A1
HK1075452A1 HK05109751.5A HK05109751A HK1075452A1 HK 1075452 A1 HK1075452 A1 HK 1075452A1 HK 05109751 A HK05109751 A HK 05109751A HK 1075452 A1 HK1075452 A1 HK 1075452A1
Authority
HK
Hong Kong
Prior art keywords
heteroarylmethylamino
piperidin
medicaments
halo
methyl
Prior art date
Application number
HK05109751.5A
Other languages
English (en)
Inventor
Bernard Vacher
Francis Colpaert
Bernard Bonnaud
Jean-Louis Maurel
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of HK1075452A1 publication Critical patent/HK1075452A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK05109751.5A 2002-06-18 2005-11-02 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments HK1075452A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207470A FR2840900B1 (fr) 2002-06-18 2002-06-18 Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments
PCT/FR2003/001873 WO2003106449A1 (fr) 2002-06-18 2003-06-18 Nouveaux derives d'aryl-{4-halogeno-4-[heteroaryl-methylamino)-methyl]-piperidin-1-yl}-methanone, leur procede de preparation et leur utilisation a titre de medicaments

Publications (1)

Publication Number Publication Date
HK1075452A1 true HK1075452A1 (en) 2005-12-16

Family

ID=29595331

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05109751.5A HK1075452A1 (en) 2002-06-18 2005-11-02 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments

Country Status (15)

Country Link
US (1) US7547700B2 (xx)
EP (1) EP1539738B1 (xx)
JP (1) JP4699027B2 (xx)
CN (1) CN1308325C (xx)
AT (1) ATE424396T1 (xx)
AU (1) AU2003258816B2 (xx)
BR (1) BRPI0311976B8 (xx)
CA (1) CA2489723C (xx)
DE (1) DE60326468D1 (xx)
ES (1) ES2321927T3 (xx)
FR (1) FR2840900B1 (xx)
HK (1) HK1075452A1 (xx)
MX (1) MXPA05000024A (xx)
WO (1) WO2003106449A1 (xx)
ZA (1) ZA200500467B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852244B1 (fr) * 2003-03-13 2007-09-07 Pf Medicament Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene
FR2891274B1 (fr) * 2005-09-27 2007-11-23 Pierre Fabre Medicament Sa Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires.
JP2011520975A (ja) * 2008-05-19 2011-07-21 ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ ピリミジンの非古典的カンナビノイド化合物及び関連する使用方法
US8389534B2 (en) * 2008-05-19 2013-03-05 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
FR2946344B1 (fr) * 2009-06-05 2012-05-25 Pf Medicament Nouveaux derives d'aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl} methanone, leur procede de preparation et leur utilisation a titre de medicaments
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
US10626105B2 (en) 2016-09-22 2020-04-21 Auspex Pharmaceuticals, Inc. Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds
EP3664787B1 (en) 2017-07-20 2022-07-20 Neurolixis Use of selective serotonin 5-ht1a receptor agonists for treating side-effects of vmat inhibitors
WO2023144166A1 (en) 2022-01-26 2023-08-03 Neurolixis Use of serotonin 5-ht1a receptor agonists to treat diseases associated with sudden unexpected death in epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN169588B (xx) * 1986-10-07 1991-11-16 Pfizer Hospital Prod
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
FR2784378B1 (fr) * 1998-10-09 2000-12-29 Pf Medicament Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2820743B1 (fr) * 2001-02-09 2005-02-25 Pf Medicament Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine

Also Published As

Publication number Publication date
AU2003258816A1 (en) 2003-12-31
BRPI0311976B1 (pt) 2015-08-18
CA2489723A1 (fr) 2003-12-24
FR2840900A1 (fr) 2003-12-19
ZA200500467B (en) 2005-12-28
ATE424396T1 (de) 2009-03-15
US20060100244A1 (en) 2006-05-11
MXPA05000024A (es) 2005-04-08
ES2321927T3 (es) 2009-06-15
DE60326468D1 (de) 2009-04-16
BR0311976A (pt) 2005-03-29
WO2003106449A8 (fr) 2005-02-17
CN1308325C (zh) 2007-04-04
EP1539738A1 (fr) 2005-06-15
CN1675194A (zh) 2005-09-28
FR2840900B1 (fr) 2005-02-25
AU2003258816B2 (en) 2008-08-21
BRPI0311976B8 (pt) 2021-05-25
JP2005534668A (ja) 2005-11-17
EP1539738B1 (fr) 2009-03-04
CA2489723C (fr) 2011-08-02
WO2003106449A1 (fr) 2003-12-24
JP4699027B2 (ja) 2011-06-08
US7547700B2 (en) 2009-06-16

Similar Documents

Publication Publication Date Title
HK1075452A1 (en) Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments
MXPA05004188A (es) Antagonistas de cgrp elegidos, procedimiento para su preparacion, asi como su empleo como medicamentos.
RS20050311A (xx) Odabrani cgrp antagonisti, postupci za njihovo dobijanje i njihovo korišćenje u vidu farmaceutskih kompozicija
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
SG158864A1 (en) Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1- carboxylic acid derivatives and related compounds
GEP20074135B (en) Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)- benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
ATE373009T1 (de) Verfahren zur vorbereitung von telithromycin
NO20054852L (no) GFAT inhibitorer
ATE444747T1 (de) Verfahren zur herstellung von expoxybutanol- zwischenprodukten
RS65604A (xx) Novi estri fluorenkarbonske kiseline, postupak za njihovo pripremanje, kao i njihova upotreba kao lekova
WO2009065919A3 (de) Organische verbindungen
NO20082388L (no) Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer
UA88812C2 (ru) Способ получения этилена и способ окисления этана
WO2009065920A3 (de) Verbindungen
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
TW200702330A (en) 3,4,5-Substituted piperidines
EP1787991A4 (en) PYRROLO [2,3-c] PYRIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
MY144180A (en) Method for producing strontium ranelate and its hydrates
WO2007012626A3 (de) Neues verfahren zur herstellung von tiotropiumsalzen
NO20082369L (no) Nye vinyloge syrederivater
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
UA94591C2 (ru) Способ получения производных сартана и промежуточных соединений, пригодных для этого способа
MX2008000821A (es) Nuevos derivados de piperidina.
MY142634A (en) Method for synthesis of (2s,3as,7as)-perhydroindole-2-carboxylic acid and esters thereof, and use in the synthesis of perindopril

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230617